Optum guides providers through important upcoming formulary updates
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
March 23, 2017 – The FDA approved new updates to the Trileptal (oxcarbazepine) drug label.
Download PDF
Return to publications
